These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

456 related items for PubMed ID: 31432563

  • 1. Paper spray mass spectrometry: A new drug checking tool for harm reduction in the opioid overdose crisis.
    Vandergrift GW, Gill CG.
    J Mass Spectrom; 2019 Sep; 54(9):729-737. PubMed ID: 31432563
    [Abstract] [Full Text] [Related]

  • 2. A new quantitative drug checking technology for harm reduction: Pilot study in Vancouver, Canada using paper spray mass spectrometry.
    Borden SA, Saatchi A, Vandergrift GW, Palaty J, Lysyshyn M, Gill CG.
    Drug Alcohol Rev; 2022 Feb; 41(2):410-418. PubMed ID: 34347332
    [Abstract] [Full Text] [Related]

  • 3. Paper spray mass spectrometry for the direct, semi-quantitative measurement of fentanyl and norfentanyl in complex matrices.
    Vandergrift GW, Hessels AJ, Palaty J, Krogh ET, Gill CG.
    Clin Biochem; 2018 Apr; 54():106-111. PubMed ID: 29432758
    [Abstract] [Full Text] [Related]

  • 4. A strategy for the detection of benzodiazepine drugs using low-resolution paper-spray mass spectrometry for harm reduction drug checking.
    Miskulin A, Wallace B, Gill C, Hore D.
    Drug Test Anal; 2024 Oct; 16(10):1085-1093. PubMed ID: 38145889
    [Abstract] [Full Text] [Related]

  • 5. Drug checking as a potential strategic overdose response in the fentanyl era.
    Laing MK, Tupper KW, Fairbairn N.
    Int J Drug Policy; 2018 Dec; 62():59-66. PubMed ID: 30359874
    [Abstract] [Full Text] [Related]

  • 6. Rapid analysis of fentanyls and other novel psychoactive substances in substance use disorder patient urine using paper spray mass spectrometry.
    Kennedy JH, Palaty J, Gill CG, Wiseman JM.
    Rapid Commun Mass Spectrom; 2018 Aug 15; 32(15):1280-1286. PubMed ID: 29757475
    [Abstract] [Full Text] [Related]

  • 7. Combining surface-enhanced Raman spectroscopy (SERS) and paper spray mass spectrometry (PS-MS) for illicit drug detection.
    Dogruer Erkok S, Gallois R, Leegwater L, Gonzalez PC, van Asten A, McCord B.
    Talanta; 2024 Oct 01; 278():126414. PubMed ID: 38950500
    [Abstract] [Full Text] [Related]

  • 8. Effect of witnessing an overdose on the use of drug checking services among people who use illicit drugs in Vancouver, Canada.
    Beaulieu T, Hayashi K, Nosova E, Milloy MJ, DeBeck K, Wood E, Kerr T, Ti L.
    Am J Drug Alcohol Abuse; 2020 Jul 03; 46(4):506-511. PubMed ID: 31983241
    [Abstract] [Full Text] [Related]

  • 9. An assessment of the limits of detection, sensitivity and specificity of three devices for public health-based drug checking of fentanyl in street-acquired samples.
    Green TC, Park JN, Gilbert M, McKenzie M, Struth E, Lucas R, Clarke W, Sherman SG.
    Int J Drug Policy; 2020 Mar 03; 77():102661. PubMed ID: 31951925
    [Abstract] [Full Text] [Related]

  • 10. Evaluating Technologies to Identify Fentanyl and Adulterants in Street Drug Paraphernalia: Qualitative Perspectives of Service Providers and Their Clientele.
    Santelices C, Matsumoto A, Boulad M, Stopka TJ.
    Subst Use Misuse; 2023 Mar 03; 58(12):1528-1535. PubMed ID: 37424449
    [Abstract] [Full Text] [Related]

  • 11. Implementation of a community-based LC-UV drug checking service: promising preliminary findings on feasibility and validity.
    Fabresse N, Papias E, Heckenroth A, Martin V, Allemann D, Roux P.
    Harm Reduct J; 2024 Oct 18; 21(1):185. PubMed ID: 39425213
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Current attitudes toward drug checking services and a comparison of expected with actual drugs present in street drug samples collected from opioid users.
    Swartz JA, Lieberman M, Jimenez AD, Mackesy-Amiti ME, Whitehead HD, Hayes KL, Taylor L, Prete E.
    Harm Reduct J; 2023 Jul 07; 20(1):87. PubMed ID: 37420196
    [Abstract] [Full Text] [Related]

  • 14. What is needed for implementing drug checking services in the context of the overdose crisis? A qualitative study to explore perspectives of potential service users.
    Wallace B, van Roode T, Pagan F, Phillips P, Wagner H, Calder S, Aasen J, Pauly B, Hore D.
    Harm Reduct J; 2020 May 12; 17(1):29. PubMed ID: 32398090
    [Abstract] [Full Text] [Related]

  • 15. Harm reduction measures employed by people using opioids with suspected fentanyl exposure in Boston, Baltimore, and Providence.
    Rouhani S, Park JN, Morales KB, Green TC, Sherman SG.
    Harm Reduct J; 2019 Jun 24; 16(1):39. PubMed ID: 31234942
    [Abstract] [Full Text] [Related]

  • 16. The potential impacts of community drug checking within the overdose crisis: qualitative study exploring the perspective of prospective service users.
    Wallace B, van Roode T, Pagan F, Hore D, Pauly B.
    BMC Public Health; 2021 Jun 16; 21(1):1156. PubMed ID: 34134698
    [Abstract] [Full Text] [Related]

  • 17. Implementing an integrated multi-technology platform for drug checking: Social, scientific, and technological considerations.
    Wallace B, Hills R, Rothwell J, Kumar D, Garber I, van Roode T, Larnder A, Pagan F, Aasen J, Weatherston J, Gozdzialski L, Ramsay M, Burek P, Azam MS, Pauly B, Storey MA, Hore D.
    Drug Test Anal; 2021 Apr 16; 13(4):734-746. PubMed ID: 33646611
    [Abstract] [Full Text] [Related]

  • 18. Recommendations from people who use drugs in Philadelphia, PA about structuring point-of-care drug checking.
    Reed MK, Borne E, Esteves Camacho T, Kelly M, Rising KL.
    Harm Reduct J; 2024 Jan 30; 21(1):26. PubMed ID: 38287409
    [Abstract] [Full Text] [Related]

  • 19. Take-home drug checking as a novel harm reduction strategy in British Columbia, Canada.
    Klaire S, Janssen RM, Olson K, Bridgeman J, Korol EE, Chu T, Ghafari C, Sabeti S, Buxton JA, Lysyshyn M.
    Int J Drug Policy; 2022 Aug 30; 106():103741. PubMed ID: 35671687
    [Abstract] [Full Text] [Related]

  • 20. Variability in the unregulated opioid market in the context of extreme rates of overdose.
    Larnder A, Saatchi A, Borden SA, Moa B, Gill CG, Wallace B, Hore D.
    Drug Alcohol Depend; 2022 Jun 01; 235():109427. PubMed ID: 35405459
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.